TF and neoplasm: In this study, we describe the development of DELFI-TF, a fragmentomics approach designed to measure tumor burden quantitatively, and demonstrate its potential for longitudinal disease monitoring in patients with cancer without the requirement of detecting mutations in tumor tissue.